VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ECCO 2017 | Renal cell carcinoma: the Emulsion and CheckMate 214 trials

Laurence Albiges, MD, PhD, from the Gustave Roussy Institute, Villejuif, France discusses promising new trials in the treatment of renal cell carcinoma at the European Cancer Congress of the European Cancer Organisation (ECCO) 2017 in Amsterdam, Netherlands. The results of the randomised Phase II Emulsion trial (NCT02498665) and the Phase III CheckMate 214 (NCT02231749) investigating the combination of VEGF inhibitors and PDL1 inhibitors will soon be released. These results have the potential to challenge the first-line standard of care.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter